THE IN VIVO EFFECT OF THYROXINE ON CITRATE CLEAVAGE ENZYME AND NADP LINKED DEHYDROGENASE ACTIVITIES.
D001275:ATP Citrate (pro-S)-Lyase; D000429:Alcohol Oxidoreductases; D005954:Glucosephosphate Dehydrogenase; D007521:Isocitrate Dehydrogenase; D050356:Lipid Metabolism; D008099:Liver / Q000201:enzymology*; D008190:Lyases; D009249:NADP; D010088:Oxidoreductases; D010600:Pharmacology; D010734:Phosphogluconate Dehydrogenase; D051381:Rats; D012106:Research; D013974:Thyroxine
D009249:NADP; D010088:Oxidoreductases; D000429:Alcohol Oxidoreductases; D007521:Isocitrate Dehydrogenase; D010734:Phosphogluconate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase; D001275:ATP Citrate (pro-S)-Lyase; D008190:Lyases; D013974:Thyroxine
ALCOHOL OXIDOREDUCTASES; EXPERIMENTAL LAB STUDY; GLUCOSEPHOSPHATE DEHYDROGENASE; HOMOGENATES; ISOCITRATE DEHYDROGENASE; LIPID METABOLISM; LIVER ENZYMOLOGY; LYASES; NADP; PHARMACOLOGY; PHOSPHOGLUCONATE DEHYDROGENASE; RATS; THYROXINE